Clinical Trial Update: Melanoma Risk Assessment & Tailored Intervention [NA]

View source ↗

Summary

A completed University of Pennsylvania trial evaluating melanoma risk assessment and a tailored intervention. No specific drug is mentioned in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Skin Cancer

Snippet

Sponsor: University of Pennsylvania | Conditions: Melanoma, Skin Cancer | NA | Status: COMPLETED